Intellia Therapeutics

top of page

Jun 26

Intellia's Chief Scientific Officer elaborates on the news that the company successfully redosed patients with a CRISPR-based and LNP delivered therapy

Laura Sepp-Lorenzino shares details of this news and offers her opinion of the significance of it, and provides an overview of Intellia's...

The future of gene editing with Intellia’s CEO

Jun 23, 2023

Company News

The future of gene editing with Intellia’s CEO

Intellia Therapeutics CEO John Leonard on where he sees gene editing fitting into the practice of medicine.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

The NYSE is the world’s largest stock exchange, offering icons and entrepreneurs the opportunity to raise capital and change the world. Our listed companies form a powerful community committed to good governance and societal impact. Industry-leading trading technology, combined with the guidance of experienced traders creates higher market quality for NYSE-market participants

Visit NYSE